Table 3 Univariate analysis of the effect of co-morbidities on survival
Non-survivors | Survivors | P value | |
|---|---|---|---|
(n = 119) | (n = 223) | ||
CRF | 11 (9.2) | 9 (4.0) | 0.05 |
Anti-coagulant therapy | 6 (5.0) | 24 (10.8) | 0.1 |
HTN | 56 (47.1) | 78 (35.0) | 0.03 |
IHD | 38 (31.9) | 49 (22.0) | 0.05 |
DM | 35 (29.4) | 39 (17.5) | 0.01 |
COPD | 1 (0.8) | 2 (0.9) | NS |
Dementia | 18 (15.1) | 1 (0.5) | <0.0001 |
CVA and/or neurologic disease | 20 (16.8) | 21 (9.4) | 0.05 |
Malignancy | 5 (4.2) | 4 (1.8) | NS |
≥3 co-morbidities | 26 (21.9) | 31 (13.9) | 0.06 |
Mean number of co-morbidities | 1.6 ± 1.1 | 1.0 ± 1.2 | <0.0001 |